Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

COSTEM 2019 | Stem cell sources: is bone marrow preferred?

Stefan Ciurea • 25 Oct 2019
COSTEM 2019
Cyclophosphamide

Stefan Ciurea, MD, University of Texas MD Anderson Cancer Center, Houston, TX, talks on current stem cell sources in the haplo-SCT setting post-cyclophosphamide and evaluates whether bone marrow is the preferred stem cell source. This interview took place at the 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) 2019, held in Berlin, Germany.

More from Stefan Ciurea

2:32
Haploidentical transplant complications: treatment approaches
Stefan Ciurea • 25 Oct 2019
2:00
Haploidentical transplantation for AML with MRD at transplantation
Stefan Ciurea • 25 Oct 2019
The content of VJHemOnc is intended for healthcare professionals